JAMA Oncology

Oncology & Cancer

Study finds cancer patients do benefit from COVID-19 vaccination

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...

Oncology & Cancer

Optimizing balance of treatments in prostate cancer

Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year ...

Oncology & Cancer

MRI may lower breast cancer deaths from variants in 3 genes

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published ...

Oncology & Cancer

2021 USPSTF lung cancer screening criteria expand eligibility

(HealthDay)—The 2021 U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening increase eligibility compared with earlier screening criteria, with reduced racial disparity, according to a study published ...

page 14 from 40